Deep-Dive Due Diligence AI Generated Report on WORK Medical Technology Group LTD Class A Ordinary Shares (WOK)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
WOK_OUT_1 [2025-03-31 05:21:39 -0400] 2340 Bytes | 605 tokens | Cum: 605 tkns (7.56% of 8k)
==========================================================================
We need a winner today and it's already 5:21:38 AM on Mon Mar 31, 2025 -0400 ... So let's find out if WORK Medical Technology (WOK) is going up or if it's going nowhere fast. So, I pulled together a bunch of data for you to look over real fast. It's at 0.599 up from 0.500001. Is there something here we can get excited about? Help me analyze.
Here's the first list of news for WORK Medical Technology:
C1 - Mar-05-25 04:01PM - WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025
C2 - Feb-28-25 09:00AM - WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
C3 - Feb-14-25 09:00AM - WORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024
C4 - Nov-27-24 08:00AM - WORK Medical Technology Group LTD's Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
C5 - Aug-29-24 04:30PM - WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters' Over-Allotment Option
C6 - Aug-26-24 01:20PM - Kingswood Capital Partners, LLC Announces Closing of $8 Million Initial Public Offering of Ordinary Shares for its Client WORK Medical Technology Group LTD. (Nasdaq: WOK)
C7 - Aug-26-24 01:20PM 01:00PM - WORK Medical Technology Group LTD Announces Closing of Initial Public Offering
C8 - Aug-23-24 04:40PM - Kingswood Capital Partners, LLC Announces Pricing of $8 Million Initial Public Offering of Ordinary Shares for its Client WORK Medical Technology Group LTD. (Nasdaq: WOK)
ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on WORK Medical Technology (WOK)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".
WOK_IN_2 [2025-03-31 05:21:39 -0400] 2 Bytes | 2 tokens | Cum: 607 tkns (7.59% of 8k)
==========================================================================
C3
WOK_OUT_3 [2025-03-31 05:21:44 -0400] 1100 Bytes | 299 tokens | Cum: 906 tkns (11.33% of 8k)
==========================================================================
Showing C3 (chunk 1 of 10): C3:
**WORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024**
Date: Feb-14-25 09:00AM
Source: (PR Newswire)
URL: https://www.prnewswire.com/news-releases/work-medical-technology-group-ltd-reports-financial-results-for-fiscal-year-2024-302377075.html
HANGZHOU, China,Feb. 14, 2025/PRNewswire/ -- WORK Medical Technology Group LTD ("WORK Medical" or the "Company") (Nasdaq:WOK), a supplier of medical devices inChina, today reported its financial results for the fiscal year endedSeptember 30, 2024.
Mr.Shuang Wu, Chairman and Chief Executive Officer of WORK Medical, remarked, "We are pleased to report our Company's performance for the fiscal year endedSeptember 30, 2024. As the lingering effects of COVID-19 gradually subside and the global business environment returns to normal, our net revenue reflects a decline primarily due to a 69.4% decrease in mask sales. We h
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
WOK_IN_4 [2025-03-31 05:21:44 -0400] 513 Bytes | 104 tokens | Cum: 1010 tkns (12.62% of 8k)
==========================================================================
WORK Medical Technology Group LTD has released its financial results for the fiscal year ending September 30, 2024. The firm, which supplies medical devices in China, highlighted a decline in net revenue due to a significant 69.4% decrease in mask sales. This decline is attributed to the easing of the COVID-19 pandemic and a return to normalcy in the global business environment. The company's Chairman and CEO, Mr. Shuang Wu, expressed satisfaction at the company's performance in light of these circumstances.
WOK_OUT_5 [2025-03-31 05:21:44 -0400] 1020 Bytes | 254 tokens | Cum: 1264 tkns (15.80% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-03-05T21:25:24Z - WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective M...
A2 - 2025-03-05T21:11:02Z - WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective M...
A3 - 2025-02-28T14:39:24Z - WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical De...
A4 - 2025-02-28T14:21:35Z - WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical De...
A5 - 2025-02-28T14:05:53Z - WORK Medical forges strategic partnership with Chartwell Medical By Investing.com...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
WOK_IN_6 [2025-03-31 05:21:44 -0400] 2 Bytes | 2 tokens | Cum: 1266 tkns (15.82% of 8k)
==========================================================================
A1
WOK_OUT_7 [2025-03-31 05:21:49 -0400] 1098 Bytes | 303 tokens | Cum: 1569 tkns (19.61% of 8k)
==========================================================================
Showing A1 (chunk 1 of 4): A1:
**WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025**Date: 2025-03-05Source: {'uri': 'manilatimes.net', 'dataType': 'news', 'title': 'The Manila times'}URL: https://www.manilatimes.net/2025/03/06/tmt-newswire/globenewswire/work-medical-technology-group-ltd-announces-implementation-of-dual-class-share-structure-effective-march-6-2025/2068104Aware Reports Fourth Quarter and Full Year 2024 Financial Results
Hangzhou, China, March 05, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the implementation of its dual-class share structure, effective March 6, 2025.
About WORK Medical Technology Group LTD
WORK Medical
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
WOK_IN_8 [2025-03-31 05:21:49 -0400] 685 Bytes | 118 tokens | Cum: 1687 tkns (21.09% of 8k)
==========================================================================
The announcement made by WORK Medical Technology Group LTD about the implementation of its dual-class share structure is significant. This type of share structure can provide the company's founders or executives with increased voting power, allowing them to retain control of the company even if they own a smaller portion of the total shares. This move can also be seen as the company’s strategy to discourage potential hostile takeovers. However, this structure might also create concerns among minority shareholders as they may feel their voting rights are diluted. The financial implications of this move would depend on the exact terms and conditions of the new share structure.
WOK_OUT_9 [2025-03-31 05:21:49 -0400] 407 Bytes | 113 tokens | Cum: 1800 tkns (22.50% of 8k)
==========================================================================
This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!
B1 - 2024-11-27T13:00:00Z - WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
WOK_IN_10 [2025-03-31 05:21:49 -0400] 2 Bytes | 2 tokens | Cum: 1802 tkns (22.53% of 8k)
==========================================================================
B1
WOK_OUT_11 [2025-03-31 05:21:52 -0400] 834 Bytes | 229 tokens | Cum: 2031 tkns (25.39% of 8k)
==========================================================================
Showing B1 (chunk 1 of 1): B1:
**WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/11/27/2988172/0/en/WORK-Medical-Technology-Group-LTD-s-Subsidiary-Hangzhou-Shanyou-Showcases-Products-at-MEDICA-Trade-Fair-2024.htmlWORK Medical Technology Group LTD's subsidiary, Hangzhou Shanyou, showcased its medical devices at the MEDICA Trade Fair 2024 in Düsseldorf, Germany, attracting interest from potential global customers and gaining insights to guide its product development and global expansion strategies.
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
WOK_IN_12 [2025-03-31 05:21:52 -0400] 335 Bytes | 61 tokens | Cum: 2092 tkns (26.15% of 8k)
==========================================================================
The subsidiary of WORK Medical Technology Group LTD, Hangzhou Shanyou, has presented its products at the MEDICA Trade Fair 2024 held in Düsseldorf, Germany. The participation in this event has helped the company attract potential global customers and gain valuable insights for its product development and global expansion strategies.
WOK_OUT_13 [2025-03-31 05:21:53 -0400] 238 Bytes | 59 tokens | Cum: 2151 tkns (26.89% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
WOK_IN_14 [2025-03-31 05:21:53 -0400] 14 Bytes | 3 tokens | Cum: 2154 tkns (26.92% of 8k)
==========================================================================
Can you please
WOK_OUT_15 [2025-03-31 05:21:59 -0400] 3199 Bytes | 816 tokens | Cum: 2970 tkns (37.12% of 8k)
==========================================================================
This is our set of metrics.
Please analyze the numbers.
+--------------------+-----------------------+------------------------+-------------------+
| Volume: 199,909 | Perf Month: -28.57% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+--------------------+-----------------------+------------------------+-------------------+
| Avg Volume: 2.26M | Perf Quarter: -89.43% | Short Float: 1.59% | ROE: - |
+--------------------+-----------------------+------------------------+-------------------+
| Rel Volume: 0.09 | Index: - | Short Ratio: 0.02 | ROI: - |
+--------------------+-----------------------+------------------------+-------------------+
| RSI (14): 24.61 | Market Cap: 7.30M | Short Interest: 0.05M | Sales Surprise: - |
+--------------------+-----------------------+------------------------+-------------------+
| ATR (14): 0.17 | Shs Outstand: 14.59M | Beta: - | EPS Surprise: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA20: -19.72% | Shs Float: 3.43M | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA50: -71.37% | Inst Own: 0.83% | Sales past 5Y: -29.02% | Earnings: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA200: -87.80% | Insider Own: 76.46% | Employees: 229 | |
+--------------------+-----------------------+------------------------+-------------------+
| Perf Week: -21.87% | Insider Trans: 0.00% | Debt/Eq: - | |
+--------------------+-----------------------+------------------------+-------------------+
The next section covers any insider trading.
If this section may be blank due to no recent filings.
[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 0.500001
Average Volume: 247442.85
30-Day High: 0.6883
30-Day Low: 0.500001
No detailed financial data available.
==== END OF FINANCIAL REPORT ====
You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.
Now, complete this report with the following:
1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE
WOK_IN_16 [2025-03-31 05:21:59 -0400] 797 Bytes | 186 tokens | Cum: 3156 tkns (39.45% of 8k)
==========================================================================
1) Brief Summary: The company has experienced significant decreases in performance over the past month (-28.57%), quarter (-89.43%), and 200-day moving average (-87.80%). The average trading volume is 2.26M, which is higher than the current volume of 199,909. The company has a small market cap of 7.30M with 76.46% insider ownership. However, there is a lack of data regarding earnings, sales, and other financial indicators which makes it difficult to fully analyze the company's performance.
2) MARKET_SCORE[NA]: Due to the lack of complete financial data, it is not possible to calculate a reliable market score.
3) PRICE_TARGET[NA]: With the missing data, we can't reliably estimate a price target.
4) AI_RPT_HEADLINE: "Significant Performance Drop But Incomplete Data Hides Full Picture"
WOK_OUT_17 [2025-03-31 05:22:02 -0400] 676 Bytes | 167 tokens | Cum: 3323 tkns (41.54% of 8k)
==========================================================================
Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)
WOK_IN_18 [2025-03-31 05:22:02 -0400] 301 Bytes | 63 tokens | Cum: 3386 tkns (42.33% of 8k)
==========================================================================
As a financial analyst, I would choose -> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes. These documents provide comprehensive information about a company's financial health, risks, and important changes in the business which would strengthen my analysis.
WOK_IN_19 [2025-03-31 05:22:03 -0400] 126 Bytes | 29 tokens | Cum: 3415 tkns (42.69% of 8k)
==========================================================================
====================================
[2025-03-31 05:22:03] # Analysis Completed
Elapsed Time: 24.78 seconds